In November, Eli Lilly later announced its own agreement with the administration to bring its GLP-1 medications to TrumpRx. The secrecy makes it impossible to determine these deals’ effectiveness in lowering some drug prices. So today, we sued, asking the court to order the administration to make the deal texts public,” Maybarduk said. Public Citizen contends that the lack of disclosure undermines accountability at a time when drug pricing remains a central political and policy issue. “The Trump administration’s failure to make these deals public reflects disdain for the transparency and accountability the American people deserve from their government,” said Zachary Shelley, the Public Citizen attorney serving as lead counsel on the lawsuit.